Brief: Enanta Pharmaceuticals Appoints Scott T. Rottinghaus, M.D., As Senior Vice President And Chief Medical Officer
08/08/2022 23:35
Aug 8 (Reuters) - Enanta Pharmaceuticals Inc ENTA.O :
* ENANTA PHARMACEUTICALS APPOINTS SCOTT T. ROTTINGHAUS,
M.D., AS
SENIOR VICE PRESIDENT AND CHIEF MEDICAL OFFICER
Source text for Eikon: ID:nBwbL2dj0a
Further company coverage: ENTA.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Enanta Pharmaceuticals
See all newsEnanta Pharmaceuticals Inc reports results for the quarter ended June 30 - Earnings Summary
Enanta Pharmaceuticals Q3 revenue misses estimates, hurt by lower royalties
Enanta Pharmaceuticals Inc expected to post a loss of 51 cents a share - Earnings Preview
Enanta Pharma Q2 loss narrows on higher AbbVie royalties, lower costs
Enanta Pharmaceuticals Q1 revenue beats estimates